TitleAssociate Professor
InstitutionMD Anderson
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76. PMID: 26059275; PMCID: PMC4808616.
      Citations: 17     Fields:    Translation:Humans
    2. Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, Conti GN, Ganzer R, Pasticier G, Thuroff S, Ward JF. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry. Prostate Cancer Prostatic Dis. 2012 Sep; 15(3):256-9. PMID: 22487909.
      Citations: 4     Fields:    Translation:Humans
    3. Ward JF, Rewcastle JC, Ukimura O, Gill IS. Focal therapy for the treatment of localized prostate cancer: a potential therapeutic paradigm shift awaiting better imaging. Curr Opin Urol. 2012 Mar; 22(2):104-8. PMID: 22273756.
      Citations: 4     Fields:    Translation:Humans
    4. Ward JF. High-intensity focused ultrasound for therapeutic tissue ablation in surgical oncology. Surg Oncol Clin N Am. 2011 Apr; 20(2):389-407, ix. PMID: 21377590.
      Citations: 5     Fields:    Translation:Humans
    5. Delacroix SE, Ward JF. Prostate cancer multifocality: impact on cancer biology and treatment recommendations. Panminerva Med. 2010 Sep; 52(3):209-16. PMID: 21045777.
      Citations: 2     Fields:    Translation:Humans
    6. Ward JF. Contemporary outcomes of focal therapy in prostate cancer: what do we know so far... World J Urol. 2010 Oct; 28(5):593-7. PMID: 20680294.
      Citations: 3     Fields:    Translation:Humans
    7. Ward JF, Nakanishi H, Pisters L, Babaian RJ, Troncoso P. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int. 2009 Aug; 104(4):490-7. PMID: 19220260.
      Citations: 17     Fields:    Translation:Humans
    8. Ward JF, Pagliaro LC, Pisters LL. Salvage therapy for radiorecurrent prostate cancer. Curr Probl Cancer. 2008 Nov-Dec; 32(6):242-71. PMID: 19064119.
      Citations: 9     Fields:    Translation:Humans
    9. Young CY, Jatoi A, Ward JF, Blute ML. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem. 2004 Apr; 11(7):909-23. PMID: 15078173.
      Citations: 1     Fields:    Translation:Humans
    10. Ward JF, Blute ML. Chemoprevention of prostate cancer. Expert Rev Anticancer Ther. 2003 Apr; 3(2):203-14. PMID: 12722880.
      Citations:    Fields:    Translation:Humans
    11. Gray Sears CL, Ward JF, Sears ST, Puckett MF, Kane CJ, Amling CL. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002 Dec; 168(6):2457-60. PMID: 12441939.
      Citations: 24     Fields:    Translation:Humans
    12. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol. 2002 Jul; 168(1):56-60. PMID: 12050492.
      Citations: 4     Fields:    Translation:Humans
    13. Kane CJ, Tarman GJ, Summerton DJ, Buchmann CE, Ward JF, O'Reilly KJ, Ruiz H, Thrasher JB, Zorn B, Smith C, Morey AF. Multi-institutional experience with buccal mucosa onlay urethroplasty for bulbar urethral reconstruction. J Urol. 2002 Mar; 167(3):1314-7. PMID: 11832721.
      Citations: 29     Fields:    Translation:Humans
    14. Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol. 2001 Nov; 166(5):1688-91. PMID: 11586203.
      Citations: 18     Fields:    Translation:Humans
    15. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, Friedrichs PA, Moul JW. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology. 2001 Nov; 58(5):723-8. PMID: 11711349.
      Citations: 28     Fields:    Translation:Humans
    16. Ward JF, Moquin RR, Maurer ST. Expanding the differential diagnosis of the acute scrotum: ventriculoperitoneal shunt herniation. Urology. 2001 Aug; 58(2):281. PMID: 11489724.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    17. Ward JF, Sands JP, Nowacki M, Amling CL. Malignant cytological washings from prostate specimens: an independent predictor of biochemical progression after radical prostatectomy. J Urol. 2001 Feb; 165(2):469-73. PMID: 11176398.
      Citations: 2     Fields:    Translation:Humans
    18. Ward JF, Cilento BG, Kaplan GW, Velling TE, Puckett M, Stock J. The ultrasonic description of postpubertal testicles in men who have undergone prepubertal orchiopexy for cryptorchidism. J Urol. 2000 May; 163(5):1448-50. PMID: 10751855.
      Citations: 1     Fields:    Translation:Humans
    19. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999 Oct; 162(4):1307-10. PMID: 10492185.
      Citations: 30     Fields:    Translation:Humans
    20. Gray C, Ward JF, Sands JP. Syncope from increased ventricular response in atrial fibrillation during voiding: a new indication for surgical management in benign prostatic hyperplasia. J Urol. 1999 Feb; 161(2):606-7. PMID: 9915461.
      Citations: 2     Fields:    Translation:Humans
    21. Ward JF, Johnstone PA, Kane CJ. Free-to-total prostate-specific antigen ratios 18-24 months following external beam radiation for adenocarcinoma of the prostate. J Surg Oncol. 1999 Feb; 70(2):91-4. PMID: 10084650.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    22. Ward JF, Kaplan GW, Mevorach R, Stock JA, Cilento BG. Refined microscopic urinalysis for red blood cell morphology in the evaluation of asymptomatic microscopic hematuria in a pediatric population. J Urol. 1998 Oct; 160(4):1492-5. PMID: 9751402.
      Citations:    Fields:    Translation:HumansCells
    23. Ward JF, Friedlander SF, Kaplan GW. Hemangioma presenting as an ulceration of the scrotum. J Urol. 1998 Jul; 160(1):182-3. PMID: 9628647.
      Citations: 1     Fields:    Translation:Humans
    24. Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Protease inhibitor-induced urolithiasis. Urology. 1997 Oct; 50(4):508-11. PMID: 9338723.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    25. Ward JF, Nowacki M, Sands JP, Conner RJ, Huisman TK. Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. J Urol. 1996 Oct; 156(4):1381-4; discussion 1384-5. PMID: 8808876.
      Citations: 2     Fields:    Translation:Humans
    26. Neoadjuvant Systemic Therapy before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity. Clinical Genitourinary Cancer. 14:130-138.
    27. Intratumoral heterogeneity. Cancer.
    28. Focal cryotherapy for localized prostate cancer. Journal of Endourology. 26:100-101.
    29. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 7:86280-86289.
    30. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine.
    31. Re. European Urology.
    32. Prostate cancer, PSA, and questions that can only be answered by clinical trials. Oncology. 21.
    33. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. Journal of Urology. 175:1303.
    34. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU International. 117:469-477.
    35. Editorial Comment. Journal of Urology. 176:2031-2032.
    36. Active surveillance monitoring. Asian Journal of Andrology. 17:882-884.
    37. Energies for Focal Ablation. 85-97.
    38. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. European Urology.
    39. Editorial comment. International Braz J Urol. 29:342-343.
    40. PSA recurrence of prostate cancer. Consultant. 46:1613-1624.
    41. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications. 7.
    42. Considerations for patient selection for focal therapy. Therapeutic Advances in Urology. 5:330-337.
    43. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 18:276-280.
    44. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World Journal of Surgical Oncology. 13.
    45. Salvage ablative therapy in prostate cancer. Urologic Oncology: Seminars and Original Investigations. 33:495.e1-495.e7.
    46. Salvage radiotherapy for PSA-only recurrence. American Journal of Urology Review. 3:366-370.
    47. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Canadian Journal of Urology. 23:8271-8277.
    WARD's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (118)
    Co-Authors (15)
    Similar People (60)
    Same Department Expand Description